title: Recurrent euglycemic diabetic ketoacidosis after discontinuation of sodium-glucose cotransporter 2 inhibitor.
authors.affiliation: Division of Endocrinology, Diabetes, Nutrition, and Metabolism, Mayo Clinic, 200 1st St SW, Rochester, MN 55905, United States. Electronic address: maraka.spyridoula@mayo.edu.
authors.forename: Spyridoula
authors.initials: S
authors.lastname: Maraka
authors.affiliation: Division of Endocrinology, Diabetes, Nutrition, and Metabolism, Mayo Clinic, 200 1st St SW, Rochester, MN 55905, United States. Electronic address: Kearns.Ann@mayo.edu.
authors.forename: Ann E
authors.initials: AE
authors.lastname: Kearns
authors.affiliation: Division of Endocrinology, Diabetes, Nutrition, and Metabolism, Mayo Clinic, 200 1st St SW, Rochester, MN 55905, United States. Electronic address: Kittah.Nana@mayo.edu.
authors.forename: Nana Esi N
authors.initials: NE
authors.lastname: Kittah
authors.affiliation: Division of Endocrinology, Diabetes, Nutrition, and Metabolism, Mayo Clinic, 200 1st St SW, Rochester, MN 55905, United States; Division of Endocrinology, Department of Medicine, National University of Ireland, Galway, Ireland. Electronic address: derek.okeeffe@gmail.com.
authors.forename: Derek T
authors.initials: DT
authors.lastname: O'Keeffe